Progesterone Reduces Pentylenetetrazol-Induced Ictal Activity of Wild-Type Mice But Not Those Deficient in Type I 5α-Reductase

Authors


Address correspondence and reprint requests to Dr. C.A. Frye at Department of Psychology, The University at Albany–SUNY, 1400 Washington Avenue, Albany, NY 12222, U.S.A. E-mail: cafrye@cnsunix.albany.edu

Abstract

Summary:  Purpose: To investigate the importance of progesterone (P4) metabolism by the 5α-reductase type I enzyme in mitigating P4 antiseizure effects.

Methods: Ovariectomized, female homozygous and heterozygous 5α-reductase type I knockout mice (n = 23) and their wild-type siblings (n = 31) were administered P4 (1.0 mg), and their pentylenetetrazol (PTZ)-induced ictal behaviors were compared with those of vehicle-administered mice (n = 49).

Results: Mice deficient in the 5α-reductase type I enzyme administered P4, or vehicle-administered control mice, had significantly shorter latencies and increased incidence of PTZ-induced hindlimb extension and death than did wild-type mice administered P4.

Conclusions: These data suggest that P4's metabolism by the 5α-reductase type I enzyme may mitigate some of P4's antiseizure effects in the PTZ-induced seizure model.

Ancillary